Clinical trials: Intracranial Pathology

Traumatic Brain Injury

Prehospital Tranexamic Acid Use for Traumatic Brain Injury

• Completed
• Age: 15 years and older
• Phase 2
• Injection or infusion
• Results posted

Primary aim: To determine the efficacy of two dosing regimens of TXA initiated in the prehospital setting in patients with moderate to severe TBI (GCS score ≤12).

Trial name

TXA (NCT01990768)

Testing

1 gram Tranexamic Acid (TXA), 2 grams TXA, 0.9% Sodium Chloride injectable

Where

12 sites in United States, Canada

Volunteers

967 people

Sponsor

University of Washington